Phenotypic and genetic screening of Klebsiella pneumoniae isolates from human UTI patients for beta-lactamases and their genetic diversity analysis by ERIC and REP PCRs.
Suresh BobbadiNazneen Bobby MohammedBindu Kiranmayi ChinnamPrakash Narayana ReddySrinivas KandhanPublished in: Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] (2023)
Klebsiella pneumoniae is one of the major nosocomial pathogens responsible for pneumoniae, septicaemia, liver abscesses, and urinary tract infections. Coordinated efforts by antibiotic stewardship and clinicians are underway to curtail the emergence of antibiotic-resistant strains. The objective of the present study is to characterize K. pneumoniae strains through antibiotic resistance screening for production of beta-lactamases (β-lactamases) such as extended spectrum beta lactamases (ESBLs), AmpC β-lactamases, and carbapenemases by phenotypic and genotypic methods and genetic fingerprinting by enterobacterial repetitive intergenic consensus-polymerase chain reaction (ERIC-PCR) and repetitive element palindromic PCR (REP-PCR). A total of 85 K. pneumoniae strains isolated from 504 human urinary tract infections (UTI) were used in this study. Only 76 isolates showed positive in phenotypic screening test (PST), while combination disc method (CDM) as phenotypic confirmatory test (PCT) confirmed 72 isolates as ESBL producers. One or more β-lactamase genes were detected by PCR in 66 isolates (91.66%, 66/72) with bla TEM gene being the most predominant (75.75%, 50/66). AmpC genes could be detected in 21 isolates (31.8%, 21/66) with FOX gene being the predominant (24.24%, 16/66), whereas NDM-I was detected in a single strain (1.51%, 1/66). Genetic fingerprinting using ERIC-PCR and REP-PCR revealed wide heterogeneity among β-lactamase producing isolates with discriminatory power of 0.9995 and 1, respectively.
Keyphrases
- klebsiella pneumoniae
- genetic diversity
- escherichia coli
- urinary tract infection
- genome wide
- multidrug resistant
- copy number
- endothelial cells
- gram negative
- real time pcr
- drug resistant
- dna methylation
- ejection fraction
- high frequency
- induced pluripotent stem cells
- genome wide identification
- palliative care
- prognostic factors
- acinetobacter baumannii
- end stage renal disease
- transcription factor
- peritoneal dialysis
- single cell
- genome wide analysis
- cystic fibrosis
- respiratory tract
- patient reported outcomes